Rx License-Rx
← Back to AI Screener Open university listing

LicenseRx asset brief

Mouse Model for Cerebral Cavernous Malformation, an Inherited Brain Disorder

National Institutes of Health Preclinical Diagnostic / Biomarker
Probability of Success

24% · grade B · Medium data confidence

Model PoS 24% (grade B, medium data confidence). Strongest signals: Data maturity, Modality feasibility. Biggest drag: IP position.

Data maturity (22%) 59

Preclinical; human data.

IP position (16%) 45

No clear patent status in public data -- treat IP as unpriced until counsel confirms.

Modality feasibility (14%) 80

Diagnostic/biomarker -- can monetize via service before full approval.

Indication pull (14%) 76

Neurology -- active buyer appetite.

Competitive whitespace (12%) 80

Under-served segment.

Translational evidence (12%) 62

Public evidence mentions: human, mouse.

Licensing readiness (10%) 94

Listed as available for licensing; established tech-transfer office; 1 public source link(s).

Unlock the full strategic deep dive

Cost to the next milestone, decisive data, relevant articles, and the partner-ready development plan for this asset.

View Operator access See what's included →